GlassScriptPhysician profile
Haylee E Flynn
NPI 1205258456
$6,181.95
in general payments reported to CMS, 2019-2025
25 companies · $711 in 2025
The $711 reported for 2025 was more than what 82% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,146 · 2022: $1,342 · 2023: $1,636 · 2024: $1,347 · 2025: $711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,694.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,190.21 | 2021-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,095.29 | 2021-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $1,015.07 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $842.44 | 2021-2025 | Leqvio |
| Pfizer INC. | $507.47 | 2021-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $157.72 | 2023 | Arcalyst |
| Philips North America LLC | $154.29 | 2022-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Ck4) Mcot |
| Atricure, INC. | $148.49 | 2024 | |
| Heartflow, INC. | $146.73 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $129.57 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $120.35 | 2021-2022 | |
| Abbott Laboratories | $99.06 | 2023-2024 | Xience Skypoint |
| Boston Scientific Corporation | $97.06 | 2023-2024 | Watchman Flx |
| Kiniksa Pharmaceuticals International, Plc | $86.96 | 2024 | Arcalyst |
| Baxter Healthcare | $85.19 | 2024 | Hillrom - Carnation Ambulatory Monitor |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $52.76 | 2021-2025 | Camzyos |
| Novo Nordisk INC | $45.63 | 2025 | Ozempic |
| Inspire Medical Systems, INC. | $35.23 | 2025 | Inspire |
| Edwards Lifesciences Corporation | $34.74 | 2024-2025 | |
| Impulse Dynamics (USA) INC. | $34.16 | 2024 | Optimizer |
| Cvrx, INC. | $27.94 | 2024 | Barostim Neo System |
| Vital Connect, INC | $20.38 | 2024 | Vitalpatch Rtm |
| Medtronic, INC. | $19.46 | 2025 | Symplicity G3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.96 | 2022 | |
| Irhythm Technologies, INC. | $17.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haylee Flynn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.